ZTS
Zoetis Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$84.22
−5.59%Price chart
Oct 7Oct 12Oct 15Oct 20Oct 23Oct 28Nov 2Nov 5
Key dataNov 5, 2026
Open$84.87
From 52W high−35.76%
Volume3.10M
Market cap$34.80B
P/E (TTM)13.9x
P/S (TTM)3.7x
Div yield1.89%
Key dataNov 5, 2026
Open
$84.87
From 52W high
−35.76%
Volume
3.10M
Market cap
$34.80B
ValuationView details →
P/E (Fwd)
13.6x
EV/EBITDA
10.6x
P/E (TTM)
13.9x
RSI (14)
75.0
MomentumView details →
1D Return
−5.59%
YTD Return
−30.57%
SummaryUpdated Jun 1, 2026
Zoetis Inc. (NYSE:ZTS) is the world's largest animal health company, founded in 1952 and spun off from Pfizer in 2013 through an initial public offering. Headquartered in Parsippany, New Jersey, the company has evolved from a pharmaceutical division into an independent leader in veterinary medicine, serving both companion animals and livestock across global markets. With operations spanning the United States and international markets, Zoetis has established itself as a dominant force in animal healthcare through decades of scientific innovation and strategic market expansion.
Similar companies
Latest newsMore news →
Zoetis Inc. reported quarterly earnings of $1.75 per share, above the Zacks Consensus Estimate of $1.51 and compared with $1.70 per share a year earlier.1h agoZoetis reported third-quarter 2026 revenue of $2.391 billion, net income of $591 million and diluted EPS of $1.44, and provided FY2026 adjusted diluted EPS guidance of $6.25 to $6.35.4h agoZoetis Inc. shares closed at $78.80, up 1.29% from the previous trading day.7d ago